Core One Labs Commences Development on Patent Pending Psychedelic Drug Formulation for the Treatment of Alzheimer’s Disease

CANNANNEW REPORT

VANCOUVER, British Columbia, May 06, 2021 (GLOBE NEWSWIRE) — Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN:… Read More…..

Excerpt only …
READ MORE BELOW
Source : Core One Labs Commences Development on Patent Pending Psychedelic Drug Formulation for the Treatment of Alzheimer’s Disease

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.